Orbimed Advisors Has Increased Its Position in Bluebird Bio (BLUE) by $11.25 Million; Lockheed Martin (LMT) Shares Rose While Acadian Asset Management Has Raised by $4.45 Million Its Position

February 15, 2018 - By Kurt Siggers

Samuel Isaly increased its stake in Bluebird Bio Inc (BLUE) by 20.55% based on its latest 2017Q3 regulatory filing with the SEC. Orbimed Advisors Llc bought 82,146 shares as the company’s stock rose 6.94% with the market. The hedge fund run by Samuel Isaly held 481,946 shares of the health care company at the end of 2017Q3, valued at $66.20 million, up from 399,800 at the end of the previous reported quarter. Orbimed Advisors Llc who had been investing in Bluebird Bio Inc for a number of months, seems to be bullish on the $10.24 billion market cap company. The stock increased 3.83% or $7.65 during the last trading session, reaching $207.25. About 626,823 shares traded. bluebird bio, Inc. (NASDAQ:BLUE) has risen 112.34% since February 15, 2017 and is uptrending. It has outperformed by 95.64% the S&P500.

Acadian Asset Management Llc increased its stake in Lockheed Martin Corp (LMT) by 618.9% based on its latest 2017Q3 regulatory filing with the SEC. Acadian Asset Management Llc bought 14,340 shares as the company’s stock rose 2.80% with the market. The institutional investor held 16,657 shares of the military and government and technical company at the end of 2017Q3, valued at $5.17M, up from 2,317 at the end of the previous reported quarter. Acadian Asset Management Llc who had been investing in Lockheed Martin Corp for a number of months, seems to be bullish on the $101.69B market cap company. The stock increased 1.26% or $4.43 during the last trading session, reaching $354.66. About 1.65M shares traded or 26.68% up from the average. Lockheed Martin Corporation (NYSE:LMT) has risen 14.19% since February 15, 2017 and is uptrending. It has underperformed by 2.51% the S&P500.

Orbimed Advisors Llc, which manages about $6.70 billion and $10.46 billion US Long portfolio, decreased its stake in Audentes Therapeutics Inc by 672,000 shares to 4.13M shares, valued at $115.67M in 2017Q3, according to the filing. It also reduced its holding in Gilead Sciences Inc (NASDAQ:GILD) by 145,400 shares in the quarter, leaving it with 1.93M shares, and cut its stake in Unitedhealth Group Inc (NYSE:UNH).

Among 25 analysts covering bluebird bio (NASDAQ:BLUE), 14 have Buy rating, 2 Sell and 9 Hold. Therefore 56% are positive. bluebird bio had 81 analyst reports since August 11, 2015 according to SRatingsIntel. On Tuesday, October 20 the stock rating was initiated by Oppenheimer with “Outperform”. The rating was downgraded by Leerink Swann to “Market Perform” on Thursday, January 25. BMO Capital Markets maintained the stock with “Buy” rating in Thursday, August 31 report. The firm earned “Sell” rating on Monday, December 11 by Cantor Fitzgerald. The firm has “Buy” rating given on Friday, November 3 by SunTrust. The company was downgraded on Monday, December 7 by Bank of America. The firm has “Sell” rating given on Monday, July 24 by Cantor Fitzgerald. The firm has “Buy” rating by Wells Fargo given on Tuesday, December 12. Cowen & Co maintained the shares of BLUE in report on Friday, June 23 with “Buy” rating. The company was maintained on Wednesday, June 14 by Morgan Stanley.

Investors sentiment increased to 1.79 in Q3 2017. Its up 0.11, from 1.68 in 2017Q2. It increased, as 35 investors sold BLUE shares while 42 reduced holdings. 45 funds opened positions while 93 raised stakes. 49.05 million shares or 2.37% more from 47.91 million shares in 2017Q2 were reported. Oppenheimer Asset Mngmt accumulated 9 shares or 0% of the stock. Winfield Associate owns 3,310 shares. Fairfield Bush & Company stated it has 2,000 shares or 0.09% of all its holdings. Hbk Invests Lp holds 1,700 shares. Royal National Bank Of Canada accumulated 9,597 shares or 0% of the stock. State Of Wisconsin Investment Board accumulated 44,032 shares. Wellington Mgmt Gp Llp stated it has 0.13% in bluebird bio, Inc. (NASDAQ:BLUE). Cornerstone Mngmt Hldgs Lc owns 0.02% invested in bluebird bio, Inc. (NASDAQ:BLUE) for 16,855 shares. D E Shaw & Incorporated has invested 0.02% in bluebird bio, Inc. (NASDAQ:BLUE). Deutsche Bank & Trust Ag invested 0.02% in bluebird bio, Inc. (NASDAQ:BLUE). Private Advisor Ltd Limited Liability Company invested 0.01% in bluebird bio, Inc. (NASDAQ:BLUE). Public Employees Retirement Systems Of Ohio owns 19,837 shares. Tci Wealth Advsr holds 11 shares. Global X Management Lc owns 210 shares. 123,179 are owned by Voloridge Management Lc.

Since August 15, 2017, it had 0 buys, and 2 sales for $9.28 million activity. 19,000 shares valued at $6.59 million were sold by HEWSON MARILLYN A on Monday, January 29. Tanner Bruce L sold $15.21M worth of Lockheed Martin Corporation (NYSE:LMT) on Tuesday, August 15. Carvalho Orlando D also sold $2.73 million worth of Lockheed Martin Corporation (NYSE:LMT) on Tuesday, August 15. Another trade for 350 shares valued at $107,167 was made by Colan Brian P on Tuesday, August 15.

Investors sentiment increased to 1.24 in 2017 Q3. Its up 0.17, from 1.07 in 2017Q2. It increased, as 43 investors sold LMT shares while 356 reduced holdings. 110 funds opened positions while 386 raised stakes. 221.38 million shares or 1.04% less from 223.70 million shares in 2017Q2 were reported. The Tennessee-based Delta Asset Mngmt Limited Liability Com Tn has invested 0.02% in Lockheed Martin Corporation (NYSE:LMT). Murphy Cap Management holds 0.4% in Lockheed Martin Corporation (NYSE:LMT) or 9,064 shares. St Germain D J has 0.07% invested in Lockheed Martin Corporation (NYSE:LMT). Copeland Limited Liability Corporation owns 21,013 shares for 0.44% of their portfolio. Atwood Palmer Inc invested 3.83% of its portfolio in Lockheed Martin Corporation (NYSE:LMT). Cetera Advisor Net Ltd Limited Liability Company owns 0.2% invested in Lockheed Martin Corporation (NYSE:LMT) for 14,024 shares. Greenleaf owns 8,668 shares. Rothschild Limited holds 3.06% or 20,692 shares. Etrade Cap Mngmt Limited Company stated it has 8,334 shares. 674 are owned by Tctc Limited Liability Com. Burt Wealth holds 410 shares. Cambridge Rech Advsrs, Iowa-based fund reported 36,111 shares. Walter Keenan Financial Consulting Company Mi Adv owns 0.16% invested in Lockheed Martin Corporation (NYSE:LMT) for 1,096 shares. Commerce Savings Bank holds 1.17% or 300,219 shares in its portfolio. Confluence Inv Mgmt has 0.32% invested in Lockheed Martin Corporation (NYSE:LMT) for 54,377 shares.

Acadian Asset Management Llc, which manages about $65.15 billion and $22.61B US Long portfolio, decreased its stake in Star Gas Partners LP (NYSE:SGU) by 41,361 shares to 504,887 shares, valued at $5.73M in 2017Q3, according to the filing. It also reduced its holding in Northfield Bancorp Inc Del (NASDAQ:NFBK) by 268,022 shares in the quarter, leaving it with 199,889 shares, and cut its stake in Voya Finl Inc (NYSE:VOYA).

Among 23 analysts covering Lockheed Martin Corporation (NYSE:LMT), 13 have Buy rating, 0 Sell and 10 Hold. Therefore 57% are positive. Lockheed Martin Corporation had 81 analyst reports since July 21, 2015 according to SRatingsIntel. The rating was upgraded by Wells Fargo to “Outperform” on Monday, September 19. Jefferies maintained Lockheed Martin Corporation (NYSE:LMT) rating on Wednesday, July 19. Jefferies has “Hold” rating and $26500 target. The stock has “Hold” rating by Cowen & Co on Wednesday, August 23. The stock of Lockheed Martin Corporation (NYSE:LMT) earned “Hold” rating by Credit Suisse on Wednesday, July 19. The firm earned “Hold” rating on Tuesday, January 30 by Credit Suisse. The company was upgraded on Wednesday, January 27 by Wolfe Research. The firm earned “Outperform” rating on Wednesday, January 6 by RBC Capital Markets. JP Morgan initiated the shares of LMT in report on Thursday, August 25 with “Neutral” rating. The stock of Lockheed Martin Corporation (NYSE:LMT) has “Hold” rating given on Monday, July 17 by Cowen & Co. The firm has “Buy” rating given on Monday, January 8 by Stifel Nicolaus.

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>